1207 related articles for article (PubMed ID: 18955683)
1. The Gilles de la Tourette syndrome-quality of life scale (GTS-QOL): development and validation.
Cavanna AE; Schrag A; Morley D; Orth M; Robertson MM; Joyce E; Critchley HD; Selai C
Neurology; 2008 Oct; 71(18):1410-6. PubMed ID: 18955683
[TBL] [Abstract][Full Text] [Related]
2. The Gilles de la Tourette Syndrome-Quality of Life Scale for children and adolescents (C&A-GTS-QOL): development and validation of the Italian version.
Cavanna AE; Luoni C; Selvini C; Blangiardo R; Eddy CM; Silvestri PR; Calì PV; Seri S; Balottin U; Cardona F; Rizzo R; Termine C
Behav Neurol; 2013; 27(1):95-103. PubMed ID: 23598902
[TBL] [Abstract][Full Text] [Related]
3. Measuring quality of life in PSP: the PSP-QoL.
Schrag A; Selai C; Quinn N; Lees A; Litvan I; Lang A; Poon Y; Bower J; Burn D; Hobart J
Neurology; 2006 Jul; 67(1):39-44. PubMed ID: 16832075
[TBL] [Abstract][Full Text] [Related]
4. The English Version of the Gilles de la Tourette Syndrome-Quality of Life Scale for Children and Adolescents (C&A-GTS-QOL).
Su MT; McFarlane F; Cavanna AE; Termine C; Murray I; Heidemeyer L; Heyman I; Murphy T
J Child Neurol; 2017 Jan; 32(1):76-83. PubMed ID: 27686095
[TBL] [Abstract][Full Text] [Related]
5. Predictors during childhood of future health-related quality of life in adults with Gilles de la Tourette syndrome.
Cavanna AE; David K; Orth M; Robertson MM
Eur J Paediatr Neurol; 2012 Nov; 16(6):605-12. PubMed ID: 22381812
[TBL] [Abstract][Full Text] [Related]
6. Determinants of quality of life in children with Gilles de la Tourette syndrome.
Bernard BA; Stebbins GT; Siegel S; Schultz TM; Hays C; Morrissey MJ; Leurgans S; Goetz CG
Mov Disord; 2009 May; 24(7):1070-3. PubMed ID: 19306279
[TBL] [Abstract][Full Text] [Related]
7. Measuring health-related quality of life in MSA: the MSA-QoL.
Schrag A; Selai C; Mathias C; Low P; Hobart J; Brady N; Quinn NP
Mov Disord; 2007 Dec; 22(16):2332-8. PubMed ID: 17914730
[TBL] [Abstract][Full Text] [Related]
8. Quality of life in Essential Tremor Questionnaire (QUEST): development and initial validation.
Tröster AI; Pahwa R; Fields JA; Tanner CM; Lyons KE
Parkinsonism Relat Disord; 2005 Sep; 11(6):367-73. PubMed ID: 16103000
[TBL] [Abstract][Full Text] [Related]
9. Development and validation of a disease-specific quality of life questionnaire for gastro-oesophageal reflux disease: the GERD-QOL questionnaire.
Chan Y; Ching JY; Cheung CM; Tsoi KK; Polder-Verkiel S; Pang SH; Quan WL; Kee KM; Chan FK; Sung JJ; Wu JC
Aliment Pharmacol Ther; 2010 Feb; 31(3):452-60. PubMed ID: 19878152
[TBL] [Abstract][Full Text] [Related]
10. The Gilles de la Tourette Syndrome-Quality of Life Scale (GTS-QOL): A Validation in Japanese Patients.
Goto R; Matsuda N; Nonaka M; Hamamoto Y; Eriguchi Y; Fujiwara M; Suzuki A; Yokoyama Y; Kano Y
Front Psychiatry; 2021; 12():797037. PubMed ID: 35046856
[No Abstract] [Full Text] [Related]
11. The role of impulse control disorders in Tourette syndrome: an exploratory study.
Frank MC; Piedad J; Rickards H; Cavanna AE
J Neurol Sci; 2011 Nov; 310(1-2):276-8. PubMed ID: 21741055
[TBL] [Abstract][Full Text] [Related]
12. Disease-specific quality of life in young patients with tourette syndrome.
Cavanna AE; Luoni C; Selvini C; Blangiardo R; Eddy CM; Silvestri PR; Calì PV; Gagliardi E; Balottin U; Cardona F; Rizzo R; Termine C
Pediatr Neurol; 2013 Feb; 48(2):111-4. PubMed ID: 23337003
[TBL] [Abstract][Full Text] [Related]
13. Measuring health-related quality of life in patients with progressive supranuclear palsy.
Schrag A; Selai C; Quinn N; Hobart J
Neurocase; 2005 Aug; 11(4):246-9. PubMed ID: 16093224
[TBL] [Abstract][Full Text] [Related]
14. Outcomes and patient-based hearing status in conductive hearing loss.
Stewart MG
Laryngoscope; 2001 Nov; 111(11 Pt 2 Suppl 98):1-21. PubMed ID: 11802001
[TBL] [Abstract][Full Text] [Related]
15. Cross-cultural adaptation and psychometric evaluation of the French version of the Gilles de la Tourette Syndrome Quality of Life Scale (GTS-QOL).
Jalenques I; Cyrille D; Derost P; Hartmann A; Lauron S; Jameux C; Tauveron-Jalenques U; Guiguet-Auclair C; Rondepierre F;
PLoS One; 2020; 15(12):e0243912. PubMed ID: 33351837
[TBL] [Abstract][Full Text] [Related]
16. Development and evaluation of an Asthma-Specific Quality of Life (A-QOL) questionnaire.
Lee EH; Kim SH; Choi JH; Jee YK; Nahm DH; Park HS
J Asthma; 2009 Sep; 46(7):716-21. PubMed ID: 19728212
[TBL] [Abstract][Full Text] [Related]
17. Development and validation of a functional dyspepsia-related quality of life (FD-QOL) scale in South Korea.
Lee EH; Hahm KB; Lee JH; Park JJ; Lee DH; Kim SK; Choi SR; Lee ST
J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 2):268-74. PubMed ID: 16460485
[TBL] [Abstract][Full Text] [Related]
18. Development and validation of a muscular dystrophy-specific functional rating scale.
Lue YJ; Su CY; Yang RC; Su WL; Lu YM; Lin RF; Chen SS
Clin Rehabil; 2006 Sep; 20(9):804-17. PubMed ID: 17005504
[TBL] [Abstract][Full Text] [Related]
19. Measurement of health-related quality of life with glaucoma: validation of the Glau-QoL 36-item questionnaire.
Béchetoille A; Arnould B; Bron A; Baudouin C; Renard JP; Sellem E; Brouquet Y; Denis P; Nordmann JP; Rigeade MC; Bassols A; Benmedjahed K; Guillemin I; Rouland JF
Acta Ophthalmol; 2008 Feb; 86(1):71-80. PubMed ID: 17725614
[TBL] [Abstract][Full Text] [Related]
20. Development of the BD-QoL: a quality of life measure specific to Behçet's disease.
Gilworth G; Chamberlain MA; Bhakta B; Haskard D; Silman A; Tennant A
J Rheumatol; 2004 May; 31(5):931-7. PubMed ID: 15124253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
